• Products
    • Overview
    • for Students
    • for Medical Schools
    • for Hospitals
    • for Industry
  • eShop
  • Product Access
  • Tutorial Videos
  • About
    • Team
    • R&D
    • Partners / Key Customers
    • News
    • FAQs
    • Technical Requirements
    • Product Help
    • EULA
    • Privacy Policy
    • VPAT 2024
  • Email Us
    • Contact
    • Request Quotation
    • Technical Support
December 1, 2020

Epicardio celebrates its 3,000th user this year

 

Epicardio Simulation™ is celebrating 8,127 accesses from 3,081 individual users worldwide this year, so far and counting.  A total of 3,881 hours were spent on the Epicardio app, with 67 minutes average daily usage.  v3.0 is now released with improved interactive tutorials, MCQ tests and quizzes, all validated by independent expert Cardiac Physiologists from Barts Heart Centre and the Royal Brompton Hospital in London, UK.

Epicardio on Boston Scientific EDUCARE New Atrial Fibrillation App

Related Posts

News

VirtualCSP released on Medtronic Academy

News

Epicardio at ACC 2025

News

Epicardio at Arab Health – WHX 2025

Recent News

  • VirtualCSP released on Medtronic Academy
  • Epicardio at ACC 2025
  • Epicardio at Arab Health – WHX 2025
  • Epicardio exceeds 50k hours of access in 2024
FAQ's
Terms of Website Use
End-User Licence Agreement
Privacy Policy
VPAT 2024

© Epicardio Ltd 2025. All Rights Reserved.
This site is owned and operated by Epicardio Ltd
UK Registration: 7585521, USA Minnesota Registration: #1034269200025

Epicardio Simulation™ is trademark of Epicardio Ltd.
Epicardio Simulation™ is Patent Pending.
App Store® and iPad® and iPhone® and the Apple logo are trademarks of Apple Inc.
Google Play® and the Google Play logo are trademarks of Google LLC.
The "Android" name and the Android logo are property of Google LLC.